ESC 365 - Plenary questions and discussion

ESC Premium Access

Plenary questions and discussion

Session: Paradigm shift in DOAC reversal - What are the current therapeutic options?

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor E. Lindhoff-Last (DE) Associate Professor E. Grove (Aarhus, DK)

Sponsored by Portola Pharmaceutials Inc.

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speakers

Professor Edelgard Lindhoff-Last

(Germany)

1 presentation

0 follower

Associate Professor Erik Lerkevang Grove

Aarhus University Hospital, Aarhus (Denmark)

3 presentations

5 followers

4 more presentations in this session

Introduction and welcome

Speaker: Associate Professor E. Grove (Aarhus, DK)

DOAC-related bleeding: demographics, risk factors & guidelines .

Speaker: Professor J. Oldgren (Uppsala, SE)

Specific reversal agent for FXa - Inhibitor treatment - What the study data reveals? .

Speaker: Doctor A. Cohen (London, GB)

From clinical evidence to patient management- How to reverse DOAC in clinical practice .

Speaker: Professor S. Middeldorp (Amsterdam, NL)

Access the full session

Paradigm shift in DOAC reversal - What are the current therapeutic options?

Speakers: Professor E. Lindhoff-Last, Associate Professor E. Grove, Associate Professor E. Grove, Professor J. Oldgren, Doctor A. Cohen...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources